Literature DB >> 3883267

Diagnosis of preeclampsia.

L C Chesley.   

Abstract

For the purpose of clinical management, any woman with an acute rise in blood pressure in the latter half of pregnancy must be regarded as having preeclampsia with the possibility of progression to eclampsia. Unfortunately, such diagnoses have been accepted uncritically in the selection of cases for clinical and laboratory studies of preeclampsia, with inevitably erroneous and contradictory conclusions about the disorder. The diagnosis of mild preeclampsia may be correct in roughly one-half of cases, but others may be latent or frank essential hypertension or any of a variety of renal diseases. In selecting cases for research, the diagnostic errors can be greatly reduced by the exclusion of all multiparas and all primigravidas without abundant proteinuria. The primigravidas should have a reliable history of normality or follow-up studies proving it, be aged 25 or less, and have hyperuricemia. The selection of cases for the study of preeclampsia demands far more rigid criteria for diagnosis than does the diagnosis for clinical management.

Entities:  

Mesh:

Year:  1985        PMID: 3883267

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  16 in total

1.  Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall.

Authors:  E DiFederico; O Genbacev; S J Fisher
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

2.  Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies.

Authors:  I Caniggia; S Grisaru-Gravnosky; M Kuliszewsky; M Post; S J Lye
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

3.  Plasma membrane-associated pY397FAK is a marker of cytotrophoblast invasion in vivo and in vitro.

Authors:  D Ilić; O Genbacev; F Jin; E Caceres; E A Almeida; V Bellingard-Dubouchaud; E M Schaefer; C H Damsky; S J Fisher
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

4.  Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts.

Authors:  Y Zhou; C H Damsky; K Chiu; J M Roberts; S J Fisher
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

Review 5.  Lighting and fattening--evolving concepts in the pathogenesis of preeclampsia.

Authors:  R N Taylor
Journal:  West J Med       Date:  1996-04

6.  Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?

Authors:  Y Zhou; C H Damsky; S J Fisher
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

7.  Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia.

Authors:  A Many; C A Hubel; S J Fisher; J M Roberts; Y Zhou
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

8.  Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia.

Authors:  K H Lim; Y Zhou; M Janatpour; M McMaster; K Bass; S H Chun; S J Fisher
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

9.  Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies.

Authors:  Alessandro Rolfo; Ariel Many; Antonella Racano; Reshef Tal; Andrea Tagliaferro; Francesca Ietta; Jinxia Wang; Martin Post; Isabella Caniggia
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

10.  Uric acid attenuates trophoblast invasion and integration into endothelial cell monolayers.

Authors:  Shannon A Bainbridge; James M Roberts; Frauke von Versen-Höynck; Jessa Koch; Lia Edmunds; Carl A Hubel
Journal:  Am J Physiol Cell Physiol       Date:  2009-06-17       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.